Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

Denmark's Lundbeck has said that efforts to build its R&D portfolio are on track to deliver four new molecular entities (NMEs ...

Since the introduction of the Open Source Initiative (OSI) in the late 1990s, statisticians have increasingly embraced the ...

Impli's biosensor – which is implanted between the dermis and subcutaneous layers of the skin – can continuously monitor the ...

The Dementia Trials Accelerator (DTA) – which will be spearheaded by the UK Dementia Research Institute (UK DRI) and Health ...

Amgen's move follows the lifting of a temporary injunction on the launch of its Pavblu-branded biosimilar by the US Court of ...

This webinar explores how immersing yourself in the patient experience can add measurable, actionable value to your approach ...

Hyntelo, one of the first Veeva AI Partners, empowers Life Sciences businesses to harness data and adopt AI solutions. Our ...

Under US law, compounding pharmacies can make and sell patent-protected drugs that are on the FDA's shortages list in limited ...

The UK medicines regulator approved Eli Lilly's Alzheimer's disease therapy Kisunla today, but the drug is too expensive to ...

A new FDA approval has given Pfizer a broader label for its respiratory syncytial virus (RSV) vaccine Abrysvo than rival ...

Pharma companies are moving their Generative AI (GenAI) investments from pilot to production through exploration, ...